These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 23527208

  • 1. Adaptation of enterovirus 71 to adult interferon deficient mice.
    Caine EA, Partidos CD, Santangelo JD, Osorio JE.
    PLoS One; 2013; 8(3):e59501. PubMed ID: 23527208
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
    Caine EA, Fuchs J, Das SC, Partidos CD, Osorio JE.
    Viruses; 2015 Nov 17; 7(11):5919-32. PubMed ID: 26593938
    [Abstract] [Full Text] [Related]

  • 3. A Single Mutation in the VP1 of Enterovirus 71 Is Responsible for Increased Virulence and Neurotropism in Adult Interferon-Deficient Mice.
    Caine EA, Moncla LH, Ronderos MD, Friedrich TC, Osorio JE.
    J Virol; 2016 Oct 01; 90(19):8592-604. PubMed ID: 27440896
    [Abstract] [Full Text] [Related]

  • 4. Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.
    Wang KT, Lin SJ, Wang HC, Chen PC, Lin JJ, Chiang JR, Chang CL, Shih DY, Lo CF, Wang DY.
    Biologicals; 2016 Jul 01; 44(4):183-190. PubMed ID: 27068365
    [Abstract] [Full Text] [Related]

  • 5. TAK - 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic mice.
    Tamura K, Kohnoe M, Takashino A, Kobayashi K, Koike S, Karwal L, Fukuda S, Vang F, Das SC, Dean HJ.
    Vaccine; 2022 May 26; 40(24):3330-3337. PubMed ID: 35501179
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
    Sun S, Jiang L, Liang Z, Mao Q, Su W, Zhang H, Li X, Jin J, Xu L, Zhao D, Fan P, An D, Yang P, Lu J, Lv X, Sun B, Xu F, Kong W, Jiang C.
    Hum Vaccin Immunother; 2014 May 26; 10(10):2885-95. PubMed ID: 25483672
    [Abstract] [Full Text] [Related]

  • 7. In Vivo Imaging with Bioluminescent Enterovirus 71 Allows for Real-Time Visualization of Tissue Tropism and Viral Spread.
    Caine EA, Osorio JE.
    J Virol; 2017 Mar 01; 91(5):. PubMed ID: 27974562
    [Abstract] [Full Text] [Related]

  • 8. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease.
    Tsou YL, Lin YW, Shao HY, Yu SL, Wu SR, Lin HY, Liu CC, Huang C, Chong P, Chow YH.
    PLoS Negl Trop Dis; 2015 Apr 01; 9(4):e0003692. PubMed ID: 25855976
    [Abstract] [Full Text] [Related]

  • 9. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection.
    Khong WX, Yan B, Yeo H, Tan EL, Lee JJ, Ng JK, Chow VT, Alonso S.
    J Virol; 2012 Feb 01; 86(4):2121-31. PubMed ID: 22130542
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns.
    Hsiao HB, Chou AH, Lin SI, Chen IH, Lien SP, Liu CC, Chong P, Liu SJ.
    J Virol; 2014 Oct 01; 88(20):11658-70. PubMed ID: 25078697
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
    Zhang Z, Dong Z, Wei Q, Carr MJ, Li J, Ding S, Tong Y, Li D, Shi W.
    J Virol; 2017 May 01; 91(9):. PubMed ID: 28250116
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of an Enterovirus 71 Vaccine Efficacy Test Using Human Scavenger Receptor B2 Transgenic Mice.
    Imura A, Sudaka Y, Takashino A, Tamura K, Kobayashi K, Nagata N, Nishimura H, Mizuta K, Koike S.
    J Virol; 2020 Feb 28; 94(6):. PubMed ID: 31896594
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice.
    Yang L, Liu Y, Li S, Zhao H, Lin Q, Yu H, Huang X, Zheng Q, Cheng T, Xia N.
    Vaccine; 2016 Nov 21; 34(48):5938-5945. PubMed ID: 27771182
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine.
    Han X, Ying XL, Zhou SL, Han T, Huang H, Jin Q, Yang F, Sun QY, Sun XX.
    Hum Vaccin Immunother; 2014 Nov 21; 10(8):2220-6. PubMed ID: 25424925
    [Abstract] [Full Text] [Related]

  • 20. Analysis of cross-reactive neutralizing antibodies in human HFMD serum with an EV71 pseudovirus-based assay.
    Zhang H, An D, Liu W, Mao Q, Jin J, Xu L, Sun S, Jiang L, Li X, Shao J, Ma H, Huang X, Guo S, Chen H, Cheng T, Yang L, Su W, Kong W, Liang Z, Jiang C.
    PLoS One; 2014 Nov 21; 9(6):e100545. PubMed ID: 24964084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.